Regulus Therapeutics Q4 Operating Expenses USD 13.746 Million

Reuters
14 Mar
March 13 (Reuters) - Regulus Therapeutics Inc ::
*REGULUS THERAPEUTICS Q4 OPERATING EXPENSES USD 13.746 MILLION
*REGULUS THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -13.746 MILLION
*REGULUS THERAPEUTICS Q4 BASIC EPS USD -0.2
*REGULUS THERAPEUTICS Q4 PRETAX PROFIT USD -12.791 MILLION
*REGULUS THERAPEUTICS Q4 NET INCOME USD -12.791 MILLION
*REGULUS THERAPEUTICS: CO EXPECTS ITS CASH RUNWAY TO EXTEND INTO EARLY 2026

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 13-MAR-202520:05:03.45 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10